Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study.
Calvo-Silveria S, González-Díaz A, Grau I, Marimón JM, Cercenado E, Quesada MD, Casabella A, Larrosa N, Yuste J, Berbel D, Alonso M, Tubau F, Belman S, Cadenas-Jiménez I, Martín-Galiano AJ, Domínguez MÁ, Martí S, Liñares J, Pallarés R, Càmara J, Ardanuy C. Calvo-Silveria S, et al. Among authors: larrosa n. Lancet Reg Health Eur. 2024 May 3;41:100913. doi: 10.1016/j.lanepe.2024.100913. eCollection 2024 Jun. Lancet Reg Health Eur. 2024. PMID: 38737571 Free PMC article.
Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
Piñana M, González-Sánchez A, Andrés C, Vila J, Creus-Costa A, Prats-Méndez I, Arnedo-Muñoz M, Saubi N, Esperalba J, Rando A, Nadal-Baron P, Quer J, González-López JJ, Soler-Palacín P, Martínez-Urtaza J, Larrosa N, Pumarola T, Antón A. Piñana M, et al. Among authors: larrosa n. J Infect. 2024 May;88(5):106153. doi: 10.1016/j.jinf.2024.106153. Epub 2024 Apr 6. J Infect. 2024. PMID: 38588960 Free article.
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Microbiol Spectr. 2024 Apr 2;12(4):e0383623. doi: 10.1128/spectrum.03836-23. Epub 2024 Mar 14. Microbiol Spectr. 2024. PMID: 38483164 Free PMC article.
Catastrophic Streptococcus pyogenes Disease: A Personalized Approach Based on Phenotypes and Treatable Traits.
Ruiz-Rodríguez JC, Chiscano-Camón L, Maldonado C, Ruiz-Sanmartin A, Martin L, Bajaña I, Bastidas J, Lopez-Martinez R, Franco-Jarava C, González-López JJ, Ribas V, Larrosa N, Riera J, Nuvials-Casals X, Ferrer R. Ruiz-Rodríguez JC, et al. Among authors: larrosa n. Antibiotics (Basel). 2024 Feb 15;13(2):187. doi: 10.3390/antibiotics13020187. Antibiotics (Basel). 2024. PMID: 38391573 Free PMC article.
Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3.
Cañada-García JE, Moure Z, Sola-Campoy PJ, Delgado-Valverde M, Cano ME, Gijón D, González M, Gracia-Ahufinger I, Larrosa N, Mulet X, Pitart C, Rivera A, Bou G, Calvo J, Cantón R, González-López JJ, Martínez-Martínez L, Navarro F, Oliver A, Palacios-Baena ZR, Pascual Á, Ruiz-Carrascoso G, Vila J, Aracil B, Pérez-Vázquez M, Oteo-Iglesias J; GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group. Cañada-García JE, et al. Among authors: larrosa n. Front Microbiol. 2023 Nov 28;14:1331657. doi: 10.3389/fmicb.2023.1331657. eCollection 2023. Front Microbiol. 2023. PMID: 38098654 Free PMC article.
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Among authors: larrosa n. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains.
Palau M, Muñoz E, Gusta MF, Larrosa N, Gomis X, Gilabert J, Almirante B, Puntes V, Texidó R, Gavaldà J. Palau M, et al. Among authors: larrosa n. Microbiol Spectr. 2023 Jun 15;11(3):e0028023. doi: 10.1128/spectrum.00280-23. Epub 2023 Apr 20. Microbiol Spectr. 2023. PMID: 37078875 Free PMC article.
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Cercenado E, Rodríguez-Baño J, Alfonso JL, Calbo E, Escosa L, Fernández-Polo A, García-Rodríguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, Horcajada JP, Larrosa N, Martínez C, Molina J, Nuvials X, Oliver A, Paño-Pardo JR, Pérez-Rodríguez MT, Ramírez P, Rey-Biel P, Vidal P, Retamar-Gentil P. Cercenado E, et al. Among authors: larrosa n. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr;41(4):238-242. doi: 10.1016/j.eimce.2022.05.013. Epub 2023 Jan 5. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36610836 Review.
75 results